Key facts
- This page summarizes Trevor Langley's Form 3 filing for FOXO TECHNOLOGIES INC. (FOXO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Sep 2024, 17:28.
Trevor Langley - 10 Sep 2024 Form 3 Insider Report for FOXO TECHNOLOGIES INC. (FOXO)
- Reporting relationship
- Director
- Issuer ticker
- FOXO
- Reported as of
- 10 Sep 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ Trevor Langley
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Trevor Langley filed Form 3 for FOXO TECHNOLOGIES INC. (FOXO) on 12 Sep 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FOXO
holding
Class A Common Stock, $0.0001 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,023,629
- Date
- 10 Sep 2024
- Ownership
- See footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares are owned by Rennova Health, Inc. ("Rennova"). Trevor Langley is a Director of Rennova. Mr. Langley disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.